Protective effects of endotoxin in a rat model of chronic inflammation are accompanied by suppressed secretion of pro-inflammatory cytokines and biphasic alteration in hypothalamo-pituitary-adrenal axis activity

Journal of Neuroendocrinology

Volumn 18, Issue 11, 2006, Pages 875-882

  Richards, L J ^a   Chover Gonzalez, A ^b   Harbuz, M S ^a   Jessop, David S ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF CÁDIZ   (Spain)

Author keywords

ACTH; Corticosterone; Cytokines; Endotoxin; HPA axis

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BRAIN PROTECTION; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORTICOSTERONE RELEASE; CORTICOTROPIN RELEASE; CYTOKINE RELEASE; HORMONE ACTION; HORMONE RESPONSE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOMODULATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CORTICOSTERONE; CYTOKINES; FOLLOW-UP STUDIES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; INTERFERON TYPE II; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, WISTAR; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33749393004     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2006.01486.x     Document Type: Article

References (58)

1. McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med 1993; 153: 2093-2101.
2. Chrousos GP. Stress, chronic inflammation, and emotional and physical well-being: Concurrent effects and chronic sequelae. J Allergy Clin Immunol 2000; 106: S275-S291.
3. Straub RH, Dhabhar FS, Bijlsma JW, Cutolo M. How psychological stress via hormones and nerve fibers may exacerbate rheumatoid arthritis. Arthritis Rheum 2005; 52: 16-26.
4. Besedovsky HO, del Rey. A. Immune-neuro-endocrine interactions: Facts and hypotheses. Front Horm Res 2002; 29: 1-14.
5. Sanders VM, Kohm AP. Sympathetic nervous system interaction with the immune system. Int Rev Neurobiol 2002; 52: 17-41.
6. Dhabhar FS, McEwen BS. Stress-induced enhancement of antigen-specific cell-mediated immunity. J Immunol 1996; 156: 2608-2615.
7. Harbuz MS. Neuroendocrinology of autoimmunity. Int Rev Neurobiol 2002; 52: 133-161.
8. Zhang YH, Lu J, Elmquist JK, Saper CB. Lipopolysaccharide activates specific populations of hypothalamic and brainstem neurons that project to the spinal cord. J Neurosci 2000; 20: 6578-6586.
9. Witek-Janusek L. Pituitary-adrenal response to bacterial endotoxin in developing rats. Am J Physiol 1988; 255: E525-E530.
10. Sarlis NJ, Chowdrey HS, Stephanou A, Lightman SL. Chronic activation of the hypothalamo-pituitary-adrenal axis and loss of circadian rhythm during adjuvant-induced arthritis in the rat. Endocrinology 1992; 130: 1775-1779.
11. Harbuz MS, Rees RG, Eckland D, Jessop DS, Brewerton D, Lightman SL. Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress. Endocrinology 1992; 130: 1394-1400.
12. Harbuz MS, Leonard JP, Lightman SL, Cuzner ML. Changes in hypothalamic corticotrophin-releasing factor and anterior pituitary pro-opiomelanocortin mRNA during the course of experimental allergic encephalomyelitis. J Neuroimmunol 1993; 45: 127-132.
13. MacPhee IA, Antoni FA, Mason DW. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med 1989; 169: 431-445.
14. Harbuz MS, Rees RG, Lightman SL. HPA axis responses to acute stress and adrenalectomy during adjuvant-induced arthritis in the rat. Am J Physiol 1993; 264: R179-R185.
15. Tilders FJ, Schmidt ED, Hoogendijk WJ, Swaab DF. Delayed effects of stress and immune activation. Baillieres Best Pract Res Clin Endocrinol Metab 1999; 13: 523-540.
16. Valles A, Marti O, Armario A. Long-term effects of a single exposure to immobilization stress on the hypothalamic-pituitary-adrenal axis: transcriptional evidence for a progressive desensitization process. Eur J Neurosci 2003; 18: 1353-1361.
17. Armario A, Marti O, Valles A, Dal-Zotto S, Ons S. Long-term effects of a single exposure to immobilization on the hypothalamic-pituitary-adrenal axis: Neurobiologic mechanisms. Ann NY Acad Sci 2004; 1018: 162-172.
18. Harbuz MS, Chover-Gonzalez A, Gibert-Rahola J, Jessop DS. Protective effect of prior acute immune challenge, but not footshock, on inflammation in the rat. Brain Behav Immun 2002; 16: 439-449.
19. Rosenthale M, Capetola R. Adjuvant arthritis: Immunopathological and hyperalgesic features. Fed Proc 1982; 41: 2577-2582.
20. Shanks N, Windle RJ, Perks PA, Harbuz MS, Jessop DS, Ingram CD, Lightman SL. Early-life exposure to endotoxin alters hypothalamic-pituitary-adrenal function and predisposition to inflammation. Proc Natl Acad Sci USA 2000; 97: 5645-5650.
21. Huitinga I, Schmidt ED, van der Cammen MJ, Binnekade R, Tilders FJ. Priming with interleukin-1beta suppresses experimental allergic encephalomyelitis in the Lewis rat. J Neuroendocrinol 2000; 12: 1186-1193.
22. Stimpson SA, Esser RE, Carter PB, Sartor RB, Cromartie WJ, Schwab JH. Lipopolysaccharide induces recurrence of arthritis in rat joints previously injured by peptidoglycan-polysaccharide. J Exp Med 1987; 165: 1688-1702.
23. Yoshino S, Sasatomi E, Mori Y, Sagai MJ. Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritis in mice. Immunology 1999; 163: 3417-3422.
24. Beishuizen A, Thijs LG. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J Endotoxin Res 2003; 9: 3-24.
25. Hossain A, Zheng CL, Kukita A, Kohashi O. Balance of Th1/Th2 cytokines associated with the preventive effect of incomplete Freund's adjuvant on the development of adjuvant arthritis in LEW rats. J Autoimmun 2001; 17: 289-295.
26. Conde GL, Renshaw D, Zubelewicz B, Lightman SL, Harbuz MS. Central LPS-induced c-fos expression in the PVN and the A1/A2 brainstem noradrenergic cell groups is altered by adrenalectomy. Neuroendocrinology 1999; 70: 175-185.
27. Dallman MF, Viau VG, Bhatnagar S, Gomez F, Lauger K, Bell ME. Corticotropin-releasing factor, corticosteroids, stress and sugar. Energy balance, the brain and behavior. In: Pfaff DW, Arnold AP, Etgen AM, Fahrbach SE, Rubin RT, eds. Hormones, Brain and Behaviour. San Diego, CA: Academic Press, 2002: 571-631.
28. Givalois L, Dornand J, Mekaouche M, Solier MD, Bristow AF, Ixart G, Siaud P, Assenmacher I, Barbanel G. Temporal cascade of plasma level surges in ACTH, corticosterone, and cytokines in endotoxin-challenged rats. Am J Physiol 1994; 267: R164-R170.
29. Myers MJ, Farrell DE, Palmer DC, Post LO. Inflammatory mediator production in swine following endotoxin challenge with or without co-administration of dexamethasone. Int J Immunopharmacol 2003; 3: 571-579.
30. Jessop DS, Eckland DJ, Todd K, Lightman SL. Osmotic regulation of hypothalamo-neurointermediate lobe corticotrophin-releasing factor-41 in the rat. J Endocrinol 1989; 120: 119-124.
31. Ohta Y, Yamane M, Sohda T, Makino H. TAK-603 selectively suppresses Th1-type cytokine production and inhibits the progression of adjuvant arthritis. Immunology 1997; 92: 75-83.
32. Reichlin S. Neuroendocrinology of acute immunity. J Endocrinol Invest 2004; 27: 48-61.
33. Janeway CA. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989; 54: 1-13.
34. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel CX, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-2088.
35. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388: 394-397.
36. Williams NA, Stasiuk LM, Nasha TO, Richards CM, Lan AK, Day MJ, Hirst TR. Prevention of autoimmune disease due to lymphocyte modulation by the B-subunit of Escherichia coli heat-labile enterotoxin. Proc Natl Acad Sci USA 1997; 94: 5290-5295.
37. Correa SG, Rodriguez-Galan MC, Rivero VE, Riera CM. Chronic varied stress modulates experimental autoimmune encephalomyelitis in Wistar rats. Brain Behav Immun 1998; 12: 134-148.
38. Dowdell KC, Gienapp IE, Stuckman S, Wardrop RM, Whitacre CC. Neuroendocrine modulation of chronic relapsing experimental autoimmune encephalomyelitis: A critical role for the hypothalamic-pituitary-adrenal axis. J Neuroimmunol 1999; 100: 243-251.
39. Strausbaugh HJ, Green PG, Dallman MF, Levine JD. Repeated, non-habituating stress suppresses inflammatory plasma extravasation by a novel, sympathoadrenal dependent mechanism. Eur J Neurosci 2003; 17: 805-812.
40. Chover-Gonzalez AJ, Jessop DS, Tejedor-Real P, Gibert-Rahola J, Harbuz MS. Onset and severity of inflammation in rats exposed to the learned helplessness paradigm. Rheumatology 2000; 39: 764-771.
41. Jessop DS, Richards LJ, Harbuz MS. Effects of stress on inflammatory autoimmune disease: Destructive or protective? Stress 2004; 7: 261-266.
42. Turnbull AV, Lee S, Rivier C. Mechanisms of hypothalamic-pituitary-adrenal axis stimulation by immune signals in the adult rat. Ann NY Acad Sci 1998; 840: 434-443.
43. Rook GA. Glucocorticoids and immune function. Baillieres Best Pract Res Clin Endocrinol Metab 1999; 13: 567-581.
44. Mozo L, Suarez A, Gutierrez C. Glucocorticoids up-regulate constitutive interleukin-10 production by human monocytes. Clin Exp Allergy 2004; 34: 406-412.
45. Valles A, Marti O, Harbuz MS, Armario A. A single lipopolysaccharide administration is sufficient to induce a long-term desensitization of the hypothalamic-pituitary-adrenal axis. Neuroscience 2002; 112: 383-389.
46. Chen R, Zhou H, Beltran J, Malellari L, Chang SL. Differential expression of cytokines in the brain and serum during endotoxin tolerance. J Neuroimmunol 2005; 163: 53-72.
47. West MA, Heagy W. Endotoxin tolerance. A review. Crit Care Med 2002; 30 (Suppl. 1): S64-S73.
48. Fan H, Cook JA. Molecular mechanisms of endotoxin tolerance. J Endotoxin Res 2004; 10: 71-84.
49. Takemura T, Makino S, Takao T, Asaba K, Suemaru S, Hashimoto K. Hypothalamic-pituitary-adrenocortical responses to single vs. repeated endotoxin lipopolysaccharide administration in the rat. Brain Res 1997; 767: 181-191.
50. Hadid R, Spinedi E, Giovambattista A, Chautard T, Gaillard RC. Decreased hypothalamo-pituitary-adrenal axis response to neuroendocrine challenge under repeated endotoxemia. Neuroimmunomodulation 1996; 3: 62-68.
51. Hadid R, Spinedi E, Daneva T, Grau G, Gaillard RC. Repeated endotoxin treatment decreases immune and hypothalamo-pituitary-adrenal axis responses: Effects of orchidectomy and testosterone therapy. Neuroendocrinology 1995; 62: 348-355.
52. Roth J, McClellan JL, Kluger MJ, Zeisberger E. Attenuation of fever and release of cytokines after repeated injections of lipopolysaccharide in guinea-pigs. J Physiol 1994; 477: 177-185.
53. Grinevich V, Ma XM, Herman JP, Jezova D, Akmayev I, Aguilera G. Effect of repeated lipopolysaccharide administration on tissue cytokine expression and hypothalamic-pituitary-adrenal axis activity in rats. J Neuroendocrinol 2001; 13: 711-723.
54. Frankenberger M, Pechumer H, Ziegler-Heitbrock HW. Interleukin-10 is upregulated in LPS tolerance. J Inflamm 1995; 45: 56-63.
55. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994; 179: 1517-1527.
56. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150: 353-360.
57. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996; 85: 307-310.
58. Tulic MK, Fiset PO, Manoukian JJ, Frenkiel S, Lavigne F, Eidelman DH, Hamid Q. Role of toll-like receptor 4 in protection by bacterial lipopolysaccharide in the nasal mucosa of atopic children but not adults. Lancet 2004; 363: 1689-1697.